doi:10.3390/nu13114014 Bravo M, Simn J, Gonzlez-Recio I, Martinez-Cruz LA, Goikoetxea-Usandizaga N, Martnez-Chantar ML
Safety through selectivity: Peptides' targeted mechanisms explain excellent safety profiles
Therapeutic interventions have shown promise in ameliorating these effects
2.5.2 Secondary endpoints The secondary endpoints were the serum ALT at 4 weeks (visit 3) and 12 weeks (visit 4), the serum AST and -GTP at 4 weeks (visit 3), 12 weeks (visit 4), and 24 weeks (visit 5), and the serum GSH at 4 weeks (visit 3), 12 weeks (visit 4), and 24 weeks (visit 5)
That does not mean it is unsafe, it means the level of certainty is not the same
The World Mental Health (WMH) survey, using the WHO Composite International Diagnostic Interview (CIDI 3.0), identified BD as one of the most disabling psychiatric conditions, with affected individuals averaging 41.2 days of role impairment per year 36.5 of which were directly attributed to BD (Grande et al., 2016
